This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Analysts Estimate American Vanguard (AVD) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
American Vanguard (AVD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Company News for Oct 17, 2019
by Zacks Equity Research
Companies In The News Are: GM, ACRS, MGM, AVD
Falling Earnings Estimates Signal Weakness Ahead for Ferroglobe (GSM)
by Zacks Equity Research
Ferroglobe (GSM) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.
American Vanguard (AVD) Tops Q2 Earnings & Sales Estimates
by Zacks Equity Research
American Vanguard (AVD) sees double-digit sales growth in its U.S. non-crop and international businesses in Q2.
American Vanguard (AVD) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
American Vanguard (AVD) delivered earnings and revenue surprises of 22.22% and 1.67%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: American Vanguard (AVD) Q2 Earnings Expected to Decline
by Zacks Equity Research
American Vanguard (AVD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ecolab's Nalco Water to Boost Public Health With New Offering
by Zacks Equity Research
Ecolab's (ECL) Nalco Water introduces a new offering - LegionGuard LG25 that will help to protect public health.
American Vanguard (AVD) Q1 Earnings Beat, Sales Lag Estimates
by Zacks Equity Research
American Vanguard (AVD) witnesses strong sales gains in international business in Q1.
New Strong Sell Stocks for May 8th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
American Vanguard (AVD) Surpasses Q1 Earnings Estimates
by Zacks Equity Research
American Vanguard (AVD) delivered earnings and revenue surprises of 8.33% and -2.71%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for May 2nd
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Kraton (KRA) to Construct Semi Works Latex Unit in Brazil
by Zacks Equity Research
Kraton's (KRA) Cariflex technology has high growth potential. The platform will boost the company's ability to capitalize on key market opportunities.
American Vanguard (AVD) Q4 Earnings Top, Sales Lag Estimates
by Anindya Barman
Acquisitions drove American Vanguard's (AVD) revenues in 2018. The company expects its global revenues to exceed $500 million in 2019.
American Vanguard (AVD) Upgraded to Buy: Here's Why
by Zacks Equity Research
American Vanguard (AVD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Chemicals Start 2019 on Soft Note With Tepid January Growth
by Anindya Barman
Trade tensions between the United States and China have clouded the prospects of the chemical industry.
American Vanguard Takes Over Agrovant & Defensive in Brazil
by Zacks Equity Research
The acquisitions help American Vanguard (AVD) expand access to the Brazilian agricultural sector.
American Vanguard Buys QPE Herbicides Products from Corteva
by Zacks Equity Research
QPE product line buyout provides American Vanguard's (AVD) crop protection business with a portfolio of herbicide brands that holds vital leadership positions in the North American market.
Zacks.com featured highlights include: Global Net, CECO, American Vanguard and Fidelity Southern
by Zacks Equity Research
Zacks.com featured highlights include: Global Net, CECO, American Vanguard and Fidelity Southern
4 Stocks to Keep an Eye On as Analysts Initiate Coverage
by Zacks Equity Research
Increased analyst coverage over the last few weeks might translate into solid price appreciation for these stocks.
American Vanguard (AVD) Q3 Earnings Top, Sales Trail Estimates
by Anindya Barman
American Vanguard (AVD) sees strong sales from its soil fumigants and Equus fungicide in Q4.
American Vanguard (AVD) Beats Q3 Earnings Estimates
by Zacks Equity Research
American Vanguard (AVD) delivered earnings and revenue surprises of 4.76% and -5.11%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
American Vanguard (AVD) Q3 Earnings Preview: What to Watch Ahead of the Release
by Zacks Equity Research
American Vanguard (AVD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Chemical - Specialty Outlook: Trade Tensions Cloud Prospects
by Zacks Equity Research
The chemical specialty industry is bearing the brunt of trade tensions between Washington and Beijing.
New Strong Sell Stocks for September 19th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
New Strong Sell Stocks for September 14th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today: